| scholarly article | Q13442814 |
| P50 | author | Fuat Balcı | Q60315138 |
| P2093 | author name string | Tijen Utkan | |
| Dilek Bayramgürler | |||
| Ayşe Karson | |||
| Tuğçe Demirtaş | |||
| P2860 | cites work | Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder | Q44573225 |
| Enriched environments influence depression-related behavior in adult mice and the survival of newborn cells in their hippocampi | Q48222808 | ||
| An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat. | Q48473848 | ||
| Long-lasting effects of chronic rTMS to treat chronic rodent model of depression | Q48546849 | ||
| Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? | Q48589388 | ||
| Th1, Th2, and Th3 cytokine alterations in major depression | Q48800676 | ||
| Effects of octreotide in chronically mild stressed rats: possible role of immune and oxidative stress pathways | Q48865789 | ||
| The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: a randomized clinical trial | Q48866081 | ||
| Influence of kynurenine treatment on open-field activity, elevated plus-maze, avoidance behaviors and seizures in rats | Q48889222 | ||
| Tumour necrosis factor receptor deficiency alters anxiety-like behavioural and neuroendocrine stress responses of mice. | Q50580837 | ||
| Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis | Q56767253 | ||
| A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice | Q28236928 | ||
| The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease | Q28239367 | ||
| Depression: a new animal model sensitive to antidepressant treatments | Q28254150 | ||
| A meta-analysis of cytokines in major depression | Q29617325 | ||
| Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression | Q29617326 | ||
| Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation | Q34065888 | ||
| Pulsed light irradiation improves behavioral outcome in a rat model of chronic mild stress | Q34158980 | ||
| Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression | Q34242827 | ||
| Depression: an inflammatory illness? | Q34261855 | ||
| The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression | Q34904703 | ||
| Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis | Q34935593 | ||
| Cytokine-induced changes in mood and behaviour: implications for 'depression due to a general medical condition', immunotherapy and antidepressive treatment | Q35017009 | ||
| Chronic mild stress-induced anhedonia: a realistic animal model of depression | Q35655537 | ||
| Cytokines and psychopathology: lessons from interferon-alpha | Q35970243 | ||
| Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. | Q36204161 | ||
| Glucocorticoids, cytokines and brain abnormalities in depression | Q36442019 | ||
| A trans-dimensional approach to the behavioral aspects of depression | Q37080557 | ||
| Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways? | Q37194695 | ||
| Comorbid depression in rheumatoid arthritis: pathophysiology and clinical implications | Q37225947 | ||
| Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management | Q37374868 | ||
| The blood-brain barrier and immune function and dysfunction | Q37576216 | ||
| Psoriasis, a model of dermatologic psychosomatic disease: psychiatric implications and treatments | Q37969835 | ||
| Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. | Q38410039 | ||
| Chronic treatment with nanoparticles exacerbate hyperthermia induced blood-brain barrier breakdown, cognitive dysfunction and brain pathology in the rat. Neuroprotective effects of nanowired-antioxidant compound H-290/51. | Q40373633 | ||
| Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats | Q40608489 | ||
| Lack of aggression and anxiolytic-like behavior in TNF receptor (TNF-R1 and TNF-R2) deficient mice | Q42107704 | ||
| Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat | Q42870379 | ||
| Favorable response to subcutaneous administration of infliximab in rats with experimental colitis | Q43070664 | ||
| Coexistence of anhedonia and anxiety-independent increased novelty-seeking behavior in the chronic mild stress model of depression | Q43177946 | ||
| Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood-brain barrier: an experimental PET study in rats | Q43234865 | ||
| Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment | Q43282207 | ||
| Chronic treatment with the selective NOP receptor antagonist [Nphe 1, Arg 14, Lys 15]N/OFQ-NH 2 (UFP-101) reverses the behavioural and biochemical effects of unpredictable chronic mild stress in rats | Q43285150 | ||
| Spike-wave discharges are necessary for the expression of behavioral depression-like symptoms | Q43293113 | ||
| Cytokine-associated emotional and cognitive disturbances in humans | Q43601371 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 335-340 | |
| P577 | publication date | 2013-01-19 | |
| P1433 | published in | Basic and Clinical Pharmacology and Toxicology | Q15724438 |
| P1476 | title | Chronic administration of infliximab (TNF-α inhibitor) decreases depression and anxiety-like behaviour in rat model of chronic mild stress. | |
| P478 | volume | 112 |
| Q94392628 | Q94392628 |
| Q58786635 | An Integrative Approach to Neuroinflammation in Psychiatric disorders and Neuropathic Pain |
| Q41874539 | Angiotensin type 1a receptors in the paraventricular nucleus of the hypothalamus control cardiovascular reactivity and anxiety-like behavior in male mice |
| Q50568569 | Comparison of stress-induced and LPS-induced depressive-like behaviors and the alterations of central proinflammatory cytokines mRNA in rats. |
| Q38165755 | Contributions of animal models to the study of mood disorders. |
| Q47874474 | Deletion of TRIM32 protects mice from anxiety- and depression-like behaviors under mild stress |
| Q36433143 | Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus |
| Q49846010 | Differential effects of acute versus chronic stress on ethanol sensitivity: evidence for interactions on both behavioral and neuroimmune outcomes. |
| Q90007085 | Effect of infliximab, a tumor necrosis factor-alpha inhibitor, on doxorubicin-induced nephrotoxicity in rats |
| Q64250106 | Exploring the Potential Antidepressant Mechanisms of TNFα Antagonists |
| Q90410809 | FGF21 Attenuated LPS-Induced Depressive-Like Behavior via Inhibiting the Inflammatory Pathway |
| Q50674962 | Hazelnut and neuroprotection: Improved memory and hindered anxiety in response to intra-hippocampal Aβ injection. |
| Q90278288 | Hypothalamus-pituitary-adrenal axis imbalance and inflammation contribute to sex differences in separation- and restraint-induced depression |
| Q37310533 | Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment. |
| Q41085679 | Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy. |
| Q47104993 | Infliximab relieves blood retinal barrier breakdown through the p38 MAPK pathway in a diabetic rat model |
| Q35744195 | Inhibition of tumor necrosis factor improves sleep continuity in patients with treatment resistant depression and high inflammation. |
| Q38623015 | Mammary Tumors Induce Central Pro-inflammatory Cytokine Expression, but Not Behavioral Deficits in Balb/C Mice. |
| Q57469273 | Medial Forebrain Bundle Deep Brain Stimulation Reverses Anhedonic-Like Behavior in a Chronic Model of Depression: Importance of BDNF and Inflammatory Cytokines |
| Q37661357 | Novel therapeutic targets in depression and anxiety: antioxidants as a candidate treatment |
| Q26749017 | Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review |
| Q51035032 | Penile constitutive nitric oxide synthase expression in rats exposed to unpredictable chronic mild stress: role of inflammation. |
| Q39182053 | Reducing Peripheral Inflammation with Infliximab Reduces Neuroinflammation and Improves Cognition in Rats with Hepatic Encephalopathy |
| Q64901870 | Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1β and tumor necrosis factor-α in elderly patients with refractory depression. |
| Q37703896 | Rheumatoid Arthritis, Depressive Symptoms and Inflammation |
| Q38893391 | Role of Adiposity-Driven Inflammation in Depressive Morbidity |
| Q38966223 | Role of Neuro-Immunological Factors in the Pathophysiology of Mood Disorders: Implications for Novel Therapeutics for Treatment Resistant Depression |
| Q34745891 | Short- and long-term effects of interleukin-2 treatment on the sensitivity of periadolescent female mice to interleukin-2 and dopamine uptake inhibitor |
| Q91967994 | Sphingosine-1-phosphate receptor 3 in the medial prefrontal cortex promotes stress resilience by reducing inflammatory processes |
| Q36665088 | Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior |
| Q89842593 | Sustained hyperammonemia induces TNF-a IN Purkinje neurons by activating the TNFR1-NF-κB pathway |
| Q38600555 | TNFα mediates stress-induced depression by upregulating indoleamine 2,3-dioxygenase in a mouse model of unpredictable chronic mild stress |
| Q64071776 | The Antidepressant-like Effect of Flavonoids from Seeds in Chronic Restraint Stress Mice via Modulation of Monoamine Regulatory Pathways |
| Q26783012 | The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments |
| Q48337539 | The link between unpredictable chronic mild stress model for depression and vascular inflammation? |
| Q38651269 | The renin-angiotensin system: a possible new target for depression |
| Q38811581 | The role of macrophage polarization on bipolar disorder: Identifying new therapeutic targets |
| Q90249688 | The role of neuroinflammation on pathogenesis of affective disorders |
| Q47785792 | Therapeutic strategies for treatment of inflammation-related depression. |
| Q37084355 | Young-Adult Male Rats' Vulnerability to Chronic Mild Stress Is Reflected by Anxious-Like instead of Depressive-Like Behaviors. |
Search more.